Abstract: A rational fuel-cell power following strategy is made according to values such as vehicle fuel-cell power, battery power, and SOC (state of charge) of a lithium-ion battery; in the same time window, effects of different fuel-cell power growth rates on SOC of the lithium-ion battery are tested according to vehicle requirements; and at the same fuel-cell growth rate, effects of different time windows on SOC of the lithium-ion battery are tested according to vehicle requirements; a proper time window and a proper fuel-cell power change rate are found, so that the SOC value of the lithium-ion battery fluctuates within a certain range. The present invention can achieve a good operation mode of power distribution between the fuel cell and the lithium-ion battery, ensuring rational utilization of resources, thereby extending the application range of the lithium-ion battery to the maximum extent.

Abstract: A European standard-based double-gun high-power quick charging system and method are disclosed. The system includes a battery management system, and at least two paths composed of corresponding charging communication modules, chargers and high-voltage charging loops, each of the chargers connected to at least one charging gun; the battery management system independently controls the charging communication module and high-voltage charging loop, and performs mapping management on a control signal and high-voltage charging loop; information interaction between different charging control units and chargers is carried out independently.

Abstract: A rational fuel-cell power following strategy is made according to values such as vehicle fuel-cell power, battery power, and SOC (state of charge) of a lithium-ion battery; in the same time window, effects of different fuel-cell power growth rates on SOC of the lithium-ion battery are tested according to vehicle requirements; and at the same fuel-cell growth rate, effects of different time windows on SOC of the lithium-ion battery are tested according to vehicle requirements; a proper time window and a proper fuel-cell power change rate are found, so that the SOC value of the lithium-ion battery fluctuates within a certain range. The present invention can achieve a good operation mode of power distribution between the fuel cell and the lithium-ion battery, ensuring rational utilization of resources, thereby extending the application range of the lithium-ion battery to the maximum extent.

Abstract: A fused tetracyclic compound and application thereof in medicine, especially as a medicament for the treatment and/or prevention of hepatitis B. A compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, in medicine, especially as a medicament for the treatment and/or prevention of hepatitis B, wherein each variable is as defined in the specification.

Abstract: An energy control method for a hybrid bus using a hydrogen fuel battery and a power battery are disclosed. The method includes the following steps: collecting motor power data; selecting an SOC value from a certain range around an average motor power value, and performing interpolation assignment on a pile power range; adding vehicle parking determination; locking a pile variable-load frequency standard, and assessing whether requirements are satisfied; determining SOH state of the battery; and adding an operation of forced pile startup during low SOC. Based on a pile system control unit, BMS and a vehicle control unit (VCU) system, the present invention can designate and optimize an energy control strategy by means of real-time data, and determine the power state of the vehicle through VCU, and add an operation of low-power power supply by the pile during parking and an operation of forced pile startup during low SOC.

Abstract: A fused tetracyclic compound and application thereof in medicine, especially as a medicament for the treatment and/or prevention of hepatitis B. A compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, in medicine, especially as a medicament for the treatment and/or prevention of hepatitis B, wherein each variable is as defined in the specification.

Abstract: A fused tricyclic compound and application thereof in medicine, especially as a medicament for the treatment and/or prevention of hepatitis B. Specifically, the present invention relates to a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variable is as defined in the specification. The present invention also relates to the use of a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.

Abstract: A fused tricyclic compound and use thereof as a medicament, in particular as a medicament for the treatment and/or prevention of hepatitis B. Specifically, a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variate is as defined in specification. The compound also includes a Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.

Abstract: A fused tricyclic compound and use thereof as a medicament, in particular as a medicament for the treatment and/or prevention of hepatitis B. Specifically, a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variate is as defined in specification. The compound also includes a Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.